Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan

There is an ongoing search for new tracers to optimize imaging of beta cell-derived tumors (insulinomas). The PAC1 receptor, expressed by insulinomas, can be used for targeting of these tumors. Here, we investigated whether radiolabeled maxadilan could be used for insulinoma imaging. Maxadilan was C...

Descripción completa

Detalles Bibliográficos
Autores principales: Joosten, Lieke, Brom, Maarten, Schäfer, Martin K. H., Boerman, Otto C., Weihe, Eberhard, Gotthardt, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431918/
https://www.ncbi.nlm.nih.gov/pubmed/28496188
http://dx.doi.org/10.1038/s41598-017-01852-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431918/
https://www.ncbi.nlm.nih.gov/pubmed/28496188
http://dx.doi.org/10.1038/s41598-017-01852-8

Ejemplares similares